Last edition
News about "Severe haemorrhage treatment"
OrganaBio LLC, RxMP Therapeutics Partner for cGMP Manufacturing of Novel Bleeding Control Therapy
OrganaBio LLC partners with RxMP Therapeutics to manufacture RMP-402, a next-generation therapy designed to rapidly stop severe bleeding in both civilian and military settings.
Severe Haemorrhage Treatment | 27/04/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members